Pro12Ala polymorphism of the PPARγ2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients

Diabetes Care

Volumn 30, Issue 5, 2007, Pages 1156-1161

  Vaccaro, Olga ^a,c   Lapice, Emanuela ^a   Monticelli, Antonella ^a,b   Giacchetti, Manuela ^a,b   Castaldo, Imma ^a,b   Galasso, Rocco ^a   Pinelli, Michele ^a,b   Donnarumma, Giovanna ^a   Rivellese, Angela A ^a   Cocozza, Sergio ^a,b   Riccardi, Gabriele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c National Council of Research ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; CREATININE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CLINICAL FEATURE; CONTROLLED STUDY; DIET; DNA POLYMORPHISM; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GENE LOCUS; GENETIC VARIABILITY; HEALTH CENTER; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; QUESTIONNAIRE; AMINO ACID SUBSTITUTION; BLOOD; DIABETIC DIET; ENERGY METABOLISM; FEEDING BEHAVIOR; GENETICS; HETEROZYGOTE DETECTION; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ADULT; AGED; ALANINE; AMINO ACID SUBSTITUTION; BODY MASS INDEX; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; ENERGY METABOLISM; FEMALE; FOOD HABITS; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; PROLINE; VARIATION (GENETICS); WEIGHT GAIN;

EID: 34247643183     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1153     Document Type: Article

References (28)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727, 2002
2. West DB, York B: Dietary fat, genetic predisposition, and obesity: lessons from animal models. Am J Clin Nutr 67 (Suppl. 3):505S-512S, 1998
3. Uusitupa M: Gene-diet interaction in relation to the prevention of obesity and type 2 diabetes: evidence from Finnish Diabetes Prevention Study. Nutr Metab Cardiovasc Dis 15:225-233, 2005
4. Cocozza S: Methodolological aspects of the assessment of gene-nutrient interactions at the population level. Nutr Metab Cardiovasc Dis 17:82-88, 2007
5. Knouff C, Auwerx J: Peroxisome proliferator activated receptor gamma calls for activation in moderation: lessons from genetics and pharmacology. Endocr Rev 25:899-918, 2003
6. Masud S, Ye S, the SAS Group: Effect of the peroxisome activated receptor γ gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 40:773-780, 2003
7. Stefanski A, Majkowska L, Ciechanowicz A, Frankow M, Safranow K, Parczewski M, Pilarska K: Lack of association between the Pro12Ala polymorphism in PPAR γ 2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes. Arch Med Res 37:736-743, 2006
8. Ek J, Urhammer TIA, Sorensen T, Auwers J, Pedersen O: Homozygosity of the Pro12Ala variant of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42:892-895, 1999
9. Luan J, Browne PO, Harding A-H, Halsall DJ, O'Rahilly S, Chatterjee VKK, Wareham NJ: Evidence for gene-nutrient interaction at the PPARγ locus. Diabetes 50:686-689, 2001
10. Robitaille J, Despres JP, Perusse L, Vohl MC: The PPARγ P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet 63:109-116, 2003
11. Lindi VI, Sivenius K, Niskanen L, Laakso M, Uusitupa MI: Effect of the Pro12Ala polymorphism of the PPARγ 2 gene on long term body weight change in Finnish non diabetic subjects. Diabetologia 44:925-926, 2001
12. Franks PW, Luan J, Browne PO, Harding AH, O'Rahilly S, Chatterjee VK, Wareham NJ: Does peroxisome proliferator activated receptor γ genotype (Pro12Ala) modify the association of physical activity and dietary fat with fasting insulin level? Metabolism 53:11-16, 2004
13. Pisaballo R, Sanguetti C, Stoll M, Prendez D: High incidence of type 2 diabetes in peroxisome proliferator-activated receptor γ2 Pro12Ala carriers exposed to a high chronic intake of trans fatty acids and saturated fatty acids. Diabetes Care 27:2251-2252, 2004
14. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willet WC, Hunter D-J: Interaction between a peroxisome proliferator-activated receptor γ gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 12:2923-2929, 2003
15. Lindi V, Schwab U, Louheranta A, Laakso M, Vessby B, Hermansen K, Storlien L, Riccardi G, Rivellese AA, Uusitupa MIJ: Impact of the Pro12Ala polymorphism of PPARγ 2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol Genet Metab 79:52-60, 2003
16. Panico S, Dello Iacovo R, Celentano E, Galasso R, Muti P, Salvatore M, Mancini M: Progetto ATENA, a study on the etiology of major chronic diseases in women: design, rationale and objectives. Eur J Epidemiol 8:601-608, 1992
17. Trevisan M, Krogh V, Ferro-Luzzi A, Riccardi G, Freudenheim J, Sette S, Scaccini C: [Food questionnaire for epidemiological studies on large cohorts for use in Italy]. Ann Ist Super Sanita 28:397-402, 1992 (in Italian)
18. Salvini S: A food composition database for epidemiological studies in Italy. Cancer Lett 114:299-300, 1997
19. Saltin B, Grimby G: Physiological analysis of middle-aged men and former athletes. Circulation 38:1104-1105, 1968
20. Nicklas BJ, Van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR: Genetic variation in the peroxisome proliferator-activated receptor-γ2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 50:2172-2176, 2001
21. Lazar MA: PPARγ,10 years later. Biochimie 87:9-13, 2005
22. Stumvoll M, Haring H: Reduced lipolysis as possible cause for greater weight gain in subjects with the Pro12Ala polymorphism in PPAR γ 2. Diabetologia 45:152-153, 2002
23. Kao L, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL: Pro12Ala of the peroxisome proliferator-activated receptor-γ2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study. Diabetes 52:1568-1572, 2003
24. Tremblay A, Boulè N, Doucet E, Woods SC: Is the insulin resistance syndrome the price to be paid to achieve body weight stability? Int J Obes 29:1295-1298, 2005
25. Lehrke M, Lazar M: The many faces of PPARγ. Cell 123:993-999, 2005
26. Tschritter O, Fritsche A, Stefan N, Haap M, Thamer C, Bachmann O, Dahl D, Maerker E, Teigeler A, Machicao F, Haring H, Stumvoll M: Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala. Metabolism 52:778-783, 2003
27. Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Iovine C, Masulli M, Colantuoni V, Riccardi G: Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator activated receptor PPAR γ 2 gene in healthy individuals. Clin Endocrinol 57:481-486, 2002
28. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G, Colantuoni V: Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes. Diabetes 48:466-1468, 1999